Shandong Jincheng Pharmaceutical & Chemical Corporation (referred to as" Jincheng Medicine ") was established in 2004, the former Shandong Jincheng Pharmaceutical & Chemical Co., Ltd. Company covers an area of 450,000 square meters, total assets of 95,795 million yuan, with Shandong Jincheng Chemical Co. Kerry, Department of Shanghai Pharmaceutical Co., Ltd. Shandong and Shandong Jincheng Pharmaceutical Co., Ltd. biological clock of three wholly owned subsidiaries. Company as a national high-tech enterprises, the State Torch Program, Shandong Province science and technology research program implementation unit, with a Fellow of the workstation, a post-doctoral workstations, two provincial-level technology center and three specialized laboratories, has been and is applying for the national patent 16.
Since its inception, has been committed to the development of pharmaceutical intermediates cephalosporins, production and sales. The company has developed into the largest manufacturer of cephalosporin antibiotic intermediates side chain, and formed a relatively complete cephalosporins pharmaceutical intermediate chain. AE-leading products include active ester, active ester ceftazidime, 30 kinds of furan ammonium salt, and Pharmaceutical Factory of Harbin Pharmaceutical Group, Fu anti-medicine, Qi Luan for, Zhuhai federal, Cabernet Franc Medicine, Suzhou East Rui, Guangzhou Baiyun Mountain and dozens of well-known pharmaceutical companies entered into a strategic partnership, the products are exported to the United States, Italy, Switzerland, Austria, India, Japan, Korea, Iran and other countries and regions.